Early research (Phase 1)Study completedNCT01353716What this trial is testingDolutegravir Renal Impairment StudyWho this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 16
Early research (Phase 1)Study completedNCT00567047What this trial is testingPharmacokinetic Study of Vildagliptin in Patients With Renal ImpairmentWho this might be right forType-2 Diabetes Novartis 96
Early research (Phase 1)Ended earlyNCT02508740What this trial is testingSingle Oral Dose of Bevenopran in Patients With Varying Degrees of Renal ImpairmentWho this might be right forRenal Impairment Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 31
Early research (Phase 1)Study completedNCT04849650What this trial is testingPK Study of IV and Oral Amisulpride in Subjects With Severe Renal ImpairmentWho this might be right forRenal Disease, End Stage Acacia Pharma Ltd 12
Early research (Phase 1)Study completedNCT07029568What this trial is testingSee How Safe a New Medicine (NNC0705-0001) is in Healthy PeopleWho this might be right forHealthy VolunteersChronic Kidney Disease Novo Nordisk A/S 116
Not applicableEnded earlyNCT02743650What this trial is testingPilot Study of Sodium Bicarbonate in Generally Healthy People With Low BicarbonateWho this might be right forChronic Kidney Disease University of Utah 7
Early research (Phase 1)Study completedNCT05800444What this trial is testingLearn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male ParticipantsWho this might be right forChronic Kidney DiseaseHealthy Volunteers Bayer 24
Early research (Phase 1)Study completedNCT06742762What this trial is testingA Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004Who this might be right forRenal Impairment AstraZeneca 16
Early research (Phase 1)Study completedNCT06397872What this trial is testingEvaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal FunctionWho this might be right forRenal Impairment Madrigal Pharmaceuticals, Inc. 28
Early research (Phase 1)Study completedNCT06352411What this trial is testingTest How BI 456906 is Taken up in the Blood of People With and Without Kidney ProblemsWho this might be right forHealthyRenal Impairment Boehringer Ingelheim 42
Early research (Phase 1)Study completedNCT05505955What this trial is testingStudy of HRS-5965 in Healthy Subjects and Subjects With Renal InsufficiencyWho this might be right forGlomerulonephritis Chengdu Suncadia Medicine Co., Ltd. 83
Early research (Phase 1)Study completedNCT02775955What this trial is testingPK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal FunctionWho this might be right forHealthy Pharmaceutical Project Solutions, Inc. 24
Early research (Phase 1)WithdrawnNCT07515339What this trial is testingLearn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy AdultsWho this might be right forChronic Kidney Disease Bayer
Early research (Phase 1)Study completedNCT02634437What this trial is testingStudy of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female SubjectsWho this might be right forRenal Function Allergan 19
Early research (Phase 1)Study completedNCT05954169What this trial is testingPharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy SubjectsWho this might be right forHyperuricemia Jiangsu HengRui Medicine Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT04320771What this trial is testingStudy on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and WeightWho this might be right forPharmacology, Clinical Bayer 18
Early research (Phase 1)Study completedNCT06814132What this trial is testingEvaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)Who this might be right forKidney Failure, ChronicEnd-Stage Kidney DiseaseRenal Failure, Chronic+2 more Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT00426036What this trial is testingEffect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of LicarbazepineWho this might be right forHealthy Novartis 12
Not applicableUnknownNCT04247867What this trial is testingCombination of Medium Cut-off Dialyzer Membrane and Diet Modification to Alleviate Residual Uremic Syndrome of Dialysis PatientsWho this might be right forEnd Stage Renal DiseaseHaemodialysisDiet, Healthy University Medical Centre Ljubljana 50
Early research (Phase 1)Study completedNCT04365218What this trial is testingEvaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease AstraZeneca 12